The in vitro pharmacology of D-Met2,Pro5-enkephalinamide.
D000818:Animals; D004723:Endorphins / Q000494:pharmacology*; D004744:Enkephalin, Methionine / Q000031:analogs & derivatives*; D004745:Enkephalins / Q000494:pharmacology*; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009271:Naltrexone / Q000494:pharmacology; D009294:Narcotics / Q000494:pharmacology; D009541:Nictitating Membrane / Q000187:drug effects; D051381:Rats; D011957:Receptors, Opioid / Q000187:drug effects; D014649:Vas Deferens / Q000187:drug effects
D004723:Endorphins; D004745:Enkephalins; D009294:Narcotics; D011957:Receptors, Opioid; D004744:Enkephalin, Methionine; D009271:Naltrexone; C021717:enkephalin, Met(2)-ProNH2(5)-